Objective: Renal artery (RA) aneurysm (RAA) is a rare and complex disease. Treatment options for a RAA include endovascular surgery and open surgery with ex vivo repair or in situ reconstruction. This study evaluated the long-term outcome after vascular reconstruction of RAAs using the tailoring technique. Tailoring or aneurysmorrhaphy means a partial resection of the aneurysm with direct suture of the remaining arterial wall.
Visceral artery aneurysms are rare vascular pathologies with an incidence of 0.1% to 2%. 1 Of these visceral artery aneurysms, 22% 2 are renal artery (RA) aneurysms (RAAs),
with an estimated incidence of 0.1%. 3 The frequency of incidentally discovered RAAs has increased because of the widespread use of modern abdominal imaging such as computed tomography and magnetic resonance imaging. 4 Atherosclerosis, fibromuscular dysplasia (FMD), and arteritis are causes for RAA. Current indications for repair are an aneurysm size >3 cm, symptomatic aneurysms (hypertension, hematuria, and flank or abdominal pain), and aneurysms of any size in women of childbearing age. Disagreement and controversy about the treatment criteria for RAAs >2 cm is present in the literature. 4 The risk of rupture is not well-known because of the rarity of the disease, which is thought to be <3% of diagnosed RAA. 4 Many authors dispute a direct correlation between aneurysm size and rupture, however. 5 Among the treatment options are observation for asymptomatic RAA, endovascular therapy, and open surgery, which includes ex vivo and in situ repair such as interposition of a venous graft or excision with end-toend anastomosis. Most RAAs have a morphology with an undilatated part of the RA and sufficient artery wall (saccular aneurysm) and are suitable for a reconstruction with the tailoring technique. Tailoring means resection of the aneurysm and direct suture of the remaining sufficient wall of the artery. Aneurysmorrhaphy is a simple common technique for aneurysm treatment.
Tailoring has been performed for RAA in our department since 1985. The objective of our study was to evaluate the long-term outcome after vascular reconstruction of RAA using the tailoring technique. 
METHODS
Between January 1990 and December 2015, 108 patients with 122 RAAs underwent a vascular reconstruction for the aneurysm. Of these patients included in the analysis, 80 patients with 88 RAAs were reconstructed using the tailoring technique. Excluded were other vascular reconstructions, such as interposition of a venous graft or excision with end-to-end anastomosis of the RA. Data were prospectively collected and retrospectively analyzed. Institutional Review Board approval was waived because of the retrospective characteristics of the study. All patients gave their written and informed consent before surgery.
The current diagnosis was provided by duplex ultrasound imaging combined with computed tomography angiography or magnetic resonance imaging. In the past, conventional angiography was the standard imaging.
The morphology of the aneurysm was an important factor for the choice of technique used for open repair. Saccular aneurysms were suitable for the tailoring technique. Tailoring or aneurysmorrhaphy means a partial resection of the aneurysm and building a normal diameter of the vessel with direct suture of the remaining arterial wall 6 (Fig 1) . This technique depends on undilated parts of the RA. The remaining arterial wall has to be sufficient for a direct suture. In our department, tailoring became the treatment option of choice for RAA at the main artery/hilum and branches with a saccular morphology in the last decade. Surgical access was gained via a retroperitoneal approach in all cases. SPSS 22.0 software (IBM Corp, Armonk, NY) was used for the statistical analyses. Continuous variables are reported as the means 6 standard deviation. The level of significance was defined at P < .05 using the t-test, Mann-Whitney U test, and Wilcoxon test for blood pressure, creatinine level, and resistant index before and after surgery. Blood pressure was measured before surgery and after hospital discharge and was analyzed using Mann-Whitney U test. The group whose hypertension was cured were patients who no longer needed antihypertensive medications. The group with improvement of hypertension were patients with a decrease in the number of antihypertensive medications. The MannWhitney U test was used to compare the group with FMD with the remaining group for change in the number of antihypertensive medications before and after surgery. Survival and patency rates were calculated with the Kaplan-Meier method.
RESULTS
RAAs were identified in 108 patients in a 26-year period, of whom 80 patients (52 women and 28 men) with 88 RAAs in 84 kidneys were treated using the tailoring technique (Fig 2, a and b ). The mean age was 52.9 6 13.6 years (range, 13-83 years). In situ reconstruction was performed in all cases. Fifty-six patients were hypertensive, 23 were asymptomatic, and the RAA in one patient was ruptured.
The RAAs were unilateral in 95.5% (right in 58 and left in 30) and bilateral in 4.5% (n ¼ 4). RAAs were located at the hilum in 77.3% (n ¼ 68), at the segmental RA in 21.6% (n ¼ 19), and at the polar RA in 1.1% (n ¼ 1). Patients' demographic information is summarized in Table I .
The mean size of the aneurysm was 21.4 6 9.7 mm (range, 8-67 mm). Our indication for repair in patients with RAA <2 cm were women in childbearing age, symptomatic aneurysm, and ruptured aneurysm. The RAA size of the ruptured aneurysm was 15 mm in a 25-year-old man. Open repair of the 8-mm small RAAs was performed with other vascular repairs, simultaneously in three cases for visceral artery aneurysms and in one case for aortic coarctation. RA stenosis (RAS) was observed as ipsilateral in 9 patients (11.3%), contralateral in 3 (3.8%), and bilateral in 1 (1.3%). The creatinine level was 0.85 6 0.21 mg/dL preoperatively and 0.90 6 0.30 mg/dL postoperatively (n ¼ 78), with no significance (P ¼ .164 by Wilcoxon test). The resistance index, obtained and measured by duplex ultrasound imaging, was 0.61 6 0.07 (n ¼ 38) preoperatively and 0.63 6 0.07 (n ¼ 57) postoperatively, with no significance (P ¼ .513 by t-test).
Early results. The overall morbidity rate was 16.3%, including bleeding in 4 patients, RAS in 3, RA occlusion in 4, RA dissection 1, and myocardial infarction in 1 (Table II) . One patient died of myocardial infarction for a 30-day mortality rate of 1.3%. The 30-day primary patency rate was 90.0%. The 30-day secondary patency rate was 95.0% in 80 patients. Redo surgery because of complications, such as thrombosis, was not successful in four patients. The first was a patient with a 67-mm RAA and history of stent angioplasty and coils. The second patient had a 20-mm arteriosclerotic RAA and occlusion of the vessel after reconstruction with an unsuccessful endovascular revision. In the third patient, with a 15-mm severely arteriosclerotic RAA, a dissection of the RA occurred after surgery and led to nephrectomy because of kidney infarction. The fourth patient had a 35-mm RAA in combination with RAS and FMD leading to occlusion of the RA with kidney infarction after surgery.
Long-term results. Follow-up data were obtained for 71 patients with 78 RAAs treated using the tailoring technique (Table III) . The mean follow-up period was 60.7 months (range, 2-229 months). The mean systolic blood pressure was 138.3 6 18.5 mm Hg at presentation and 128.3 þ 13.1 mm Hg after hospital discharge at the time of the follow up. Blood pressures were measured at presentation and after hospital discharge. A comparison of systolic and diastolic rates using the Mann-Whitney U test showed a statistically significant difference (P < .001 for systolic pressure and P ¼ .002 for diastolic pressure). A comparison of the FMD group vs the remaining group with the Mann-Whitney U test showed no significance for D systolic blood pressure rates before and after surgery. However, there was a statistically significant difference for D diastolic blood pressure (P ¼ .004). In 76.4% of patients (42 of 55 with RAA and hypertension), the RAA reconstruction led simultaneously to cure (n ¼ 4) or improvement of hypertension (n ¼ 38). One hypertensive patient was lost to follow-up. Hypertension was cured or improved in 69.6% (16 of The long-term patency after RAA reconstruction was demonstrated in a Kaplan-Meier curve. The estimated mean time was 204.5 6 9.5 months, with an cumulative Ten patients were lost to follow-up. During follow-up, 3 RA occlusions (3.8%), 1 RAS (1.3%), 1 stenosis of a segmental RA (1.3%), and 1 nephrectomy (1.3%) were observed (Fig 4) . The differences between the FMD group and the remaining patients were not significant when patency and the number of antihypertensive medications were compared; however, when the D blood pressure was compared between the FMD group and the remaining patients, there was a statistically significant difference in D diastolic blood pressure (P ¼.004).
DISCUSSION
RAA is a rare disease, with an incidence between 0.1% (autopsy) and 1.3% (angiography). 7 Indications for treatment are rupture, current a size >3 cm (a size >2 cm in the past), 5 renovascular hypertension, flank pain, hematuria, distal embolization, and an aneurysm in a woman of childbearing age because of a higher risk of rupture, with a high rate of maternal and fetal mortality during pregnancy.
8-10
Wayne et al 11 studied anatomic characteristics and changes in aneurysm size. They concluded that the risk of short-term growth or rupture is low. The authors recommend an indication for treatment of a size >2.5 cm in maximum diameter in asymptomatic patients (women of childbearing age excluded). 11 A multi-institutional study with 865 RAAs, of which 241 were surgically repaired, reported a rare rupture rate of asymptomatic RAAs with a growth rate of 0.086 cm/y with no difference for calcified or noncalcified aneurysms. 5 In their conclusion, they discussed that the indication for a treatment should be at a size >3 cm for asymptomatic RAAs. 5 These recent findings emphasize that the size criteria of >2 cm for operative repair was too aggressive and that new guidelines should suggest a size >3 cm for asymptomatic RAAs (excluding women of childbearing age).
The mean aneurysm size in our study was 21.4 6 9.7 mm (range, 8-67 mm). Generally, our indication for surgery was an RAA size >2 cm, aneurysm rupture, and patients with risk factors such as difficult-to-control hypertension or renal function at risk and an RAA size <2 cm. Renovascular hypertension is frequently associated with RAA. Additional RAS is associated with RAA in 53% to 66% of cases. 12 Hypertension in 50% to 100%
can be cured or improved after surgical reconstruction of an RAA. Hypertension was the leading symptom in our study (57 [71.2%]), and 22.8% of the hypertension patients had an additional RAS. Hypertension was cured in 7.1% and improved in 67.9% of RAA patients, and was improved in 61.6% of patients with RAS. The profit in regard to hypertension for patients with RAA and additional RAS is higher after a reconstruction of a RAA, 13 but a repair of an isolated RAA cured or improved hypertension as well. Our study shows a correlation between cured or improved hypertension and RAA reconstruction in 76%. Improvement of hypertension in patients with RAA and additional RAS has been described. 13 The mechanisms of macroembolism and microembolism into the renal parenchyma from the RAA, coexistent RA occlusive disease, compression or kinking of associated RA branches, and hemodynamic disturbance by turbulent blood flow in the RAA might result in decreased blood flow in distal RA perfusion and, therefore, may explain the correlation between RAA and hypertension. 14 From the cured or improved patients with hypertension, 60.7% in our study had only an RAA without any RA lesion. This might be an indirect sign of the correlation, but we had no evidence for this hypothesis in our study. Mortality and renal function after reconstruction of RAA are acceptable. The morbidity and mortality were very low for surgical repair of RAAs. 8, 15, 16 The largest study, with 252 RAAs from Henke et al, 15 showed an excellent outcome, with low morbidity (perioperative complications in 5 patients, further intervention in 7 patients, long-term complication with renal failure with hemodialysis in 1 patient) and no deaths. 15 Our study, with 80 patients and 88 RAAs, shows a good outcome as well. The 30-day mortality was 1.3%, and overall morbidity was 16.3% (4 with bleeding, 8 with RA lesion and further intervention, and 1 with myocardial infarction). The 30-day primary patency rate was 90.0%, and the 30-day secondary patency rate was 95.0% in 80 patients. The long-term outcome was good as well, with a cumulative patency rate of 98.7%, 97.4%, 94.8%, and 92.3% after 18, 24, 36, and 48 months, respectively, for all reconstructions, and 96% after 12 months and 92% after 36 months for FMD patients. One patient required nephrectomy but without renal failure requiring hemodialysis. The indication for surgery of an asymptomatic RAA is to prevent rupture. Studies have reported rupture rates between 0% and 14%, but most authors see the true rate at 3%. 4 Three ruptured RAA (1.2%) were present in the Henkes et al 15 study, but many other studies reported no ruptures. 4, 11, 17 We observed one rupture (1.3%) and confirmed that a RAA rupture is a rare condition. The various treatment options for an RAA include ex vivo repair or in situ reconstruction, with or without cold preservation and orthotopic or heterotopic autotransplantation of the kidney. Another technique is described by Gallagher The tailoring technique is a simple in situ repair and shows an excellent long-term outcome for normal and complex lesions, as well. The tailoring technique can be used for all types of RAA lesions without removing the kidney from its anatomic position and with a good long-term outcome. Other in situ reconstructions include resection and reanastomosis, venous or prosthetic graft interposition, or bypassing.
Use of the tailoring technique is contingent on a sufficient undilated part of the artery. We combined tailoring with other in situ reconstructions, including resection and reanastomosis, graft interposition, or bypassing in cases when the technique was not successful. Tailoring has been performed for RAA reconstruction in our department since 1985. In a former study , the tailoring technique was performed in 35% of RAA reconstructions. 12 In this study , the tailoring technique was performed in 72.7% (88 of 122) as the only treatment option for RAA. In eight more cases, tailoring was combined with a saphenous vein graft in complex lesions (96 [78.7%]). We see a trend with an increasing number in using tailoring for RAA in the last decade. The tailoring technique has now become the standard treatment option for RAA in our department because of the excellent long-term outcome. Tailoring is a safe and effective option for RAA with good long-term results. Our study is, however, limited by its retrospective nature, and as a single-center study, in general validity.
CONCLUSIONS
The tailoring technique is a safe and effective procedure for all kinds of RAA with good long-term outcomes. Indication for a treatment should be considered at a size >3 cm for asymptomatic RAAs and for those in women of childbearing age. Renovascular hypertension was cured or improved in 76% of patients with RAA and hypertension. 
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